These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30401707)

  • 1. Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia.
    Rivella S
    Blood; 2019 Jan; 133(1):51-58. PubMed ID: 30401707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.
    Ginzburg Y; Rivella S
    Blood; 2011 Oct; 118(16):4321-30. PubMed ID: 21768301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.
    Gardenghi S; Grady RW; Rivella S
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1089-107. PubMed ID: 21075282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic targets in transfusion-dependent and -independent thalassemia.
    Cappellini MD; Motta I
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia.
    Suragani RN; Cawley SM; Li R; Wallner S; Alexander MJ; Mulivor AW; Gardenghi S; Rivella S; Grinberg AV; Pearsall RS; Kumar R
    Blood; 2014 Jun; 123(25):3864-72. PubMed ID: 24795345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.
    Rivella S
    Blood Rev; 2012 Apr; 26 Suppl 1(0 1):S12-5. PubMed ID: 22631035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ineffective erythropoiesis and its treatment.
    Cazzola M
    Blood; 2022 Apr; 139(16):2460-2470. PubMed ID: 34932791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron metabolism and ineffective erythropoiesis in beta-thalassemia mouse models.
    Ramos P; Melchiori L; Gardenghi S; Van-Roijen N; Grady RW; Ginzburg Y; Rivella S
    Ann N Y Acad Sci; 2010 Aug; 1202():24-30. PubMed ID: 20712768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ineffective Erythropoiesis: Anemia and Iron Overload.
    Gupta R; Musallam KM; Taher AT; Rivella S
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):213-221. PubMed ID: 29458727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions.
    Kalleda N; Flace A; Altermatt P; Ingoglia G; Doucerain C; Nyffenegger N; Dürrenberger F; Manolova V
    Haematologica; 2023 Oct; 108(10):2703-2714. PubMed ID: 37165842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ineffective erythropoiesis and regulation of iron status in iron loading anaemias.
    Camaschella C; Nai A
    Br J Haematol; 2016 Feb; 172(4):512-23. PubMed ID: 26491866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
    Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
    Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoiesis in lower-risk myelodysplastic syndromes and beta-thalassemia.
    Cappellini MD; Taher AT; Verma A; Shah F; Hermine O
    Blood Rev; 2023 May; 59():101039. PubMed ID: 36577601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Damage of iron metabolism and oxidoreduction process in children with beta-thalassemia].
    Mtvarelidze ZG; Kvezereli-Kopadze AN; Kvezereli-Kopadze MN
    Georgian Med News; 2006 Jul; (136):69-71. PubMed ID: 16905850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ineffective erythropoiesis and thalassemias.
    Rivella S
    Curr Opin Hematol; 2009 May; 16(3):187-94. PubMed ID: 19318943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin and Anemia: A Tight Relationship.
    Pagani A; Nai A; Silvestri L; Camaschella C
    Front Physiol; 2019; 10():1294. PubMed ID: 31649559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.
    Gardenghi S; Marongiu MF; Ramos P; Guy E; Breda L; Chadburn A; Liu Y; Amariglio N; Rechavi G; Rachmilewitz EA; Breuer W; Cabantchik ZI; Wrighting DM; Andrews NC; de Sousa M; Giardina PJ; Grady RW; Rivella S
    Blood; 2007 Jun; 109(11):5027-35. PubMed ID: 17299088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
    Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
    Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.
    Casu C; Pettinato M; Liu A; Aghajan M; Lo Presti V; Lidonnici MR; Munoz KA; O'Hara E; Olivari V; Di Modica SM; Booten S; Guo S; Neil G; Miari R; Shapir N; Zafir-Lavie I; Domev H; Ferrari G; Sitara D; Nai A; Rivella S
    Blood; 2020 Oct; 136(17):1968-1979. PubMed ID: 32556142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ineffective erythropoiesis in beta-thalassemia major is due to apoptosis at the polychromatophilic normoblast stage.
    Mathias LA; Fisher TC; Zeng L; Meiselman HJ; Weinberg KI; Hiti AL; Malik P
    Exp Hematol; 2000 Dec; 28(12):1343-53. PubMed ID: 11146156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.